Completed NA INTERVENTIONAL 1-arm NCT01270555

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Efficacy Of Bupropion SR For Attention Deficit Hyperactivity Disorder (ADHD) In Adults With Recent Past or Current Substance Use Disorders

Sponsor: Massachusetts General Hospital

Conditions Attention Deficit Hyperactivity Disorder (ADHD) Substance Use Disorder (SUD)

Interventions Bupropion SR

Updated 8 times since 2017 Last updated: Mar 4, 2013 Started: May 31, 1999 Primary completion: Jul 31, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD), this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 8 data snapshots since 1999. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

May 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.